4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-18-001317
Options or other derivatives
- VP CORPORATE DEVELOPMENT acquired 265,000 shares (grant or award)
- VP CORPORATE DEVELOPMENT returned 265,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | D | ||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | D | ||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | D | ||
| MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +100,000 | 250,000 | D | ||
Loading xslF345X03/form4-08312018_020834.xml…